HOLX vs LINE · P/E 32, rev $4.10B vs rev $5.34B
Hologic Inc (HOLX) versus Lineage, Inc. Common Stock (LINE) — a side-by-side from cached financials, not a winner call.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Lineage, Inc. Common Stock (LINE) is a reit - industrial company listed on NASDAQ.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Latest reported LINE revenue for 2024-12-31 was $5.34B. Net income was -$751.0M. Revenue was down 0.0% from 2023-12-31 to 2024-12-31. LINE currently screens at market cap $10.41B.
HOLX currently screens at market cap $16.97B and trailing P/E 31.5. LINE currently screens at market cap $10.41B.
Not investment advice. Open the HOLX and LINE stock pages for the full models.
Not investment advice.